Pathak A, Agrawal D
Arch Microbiol Immunol. 2025; 9(1):38-53.
PMID: 40051430
PMC: 11883900.
Woolls M, Mott M, Poole C, Gregory J, Ivester H, Allen I
Immunol Rev. 2025; 330(1):e13429.
PMID: 39878363
PMC: 11776368.
DOI: 10.1111/imr.13429.
Sumarokova M, Pavlov R, Lavushchenko T, Vasilenko E, Kozhemyakin G, Fedorov O
Int J Mol Sci. 2025; 26(2).
PMID: 39859399
PMC: 11765642.
DOI: 10.3390/ijms26020686.
Alqaaf M, Nasution A, Karim M, Rumman M, Sedayu M, Supriyanti R
Sci Rep. 2025; 15(1):200.
PMID: 39747174
PMC: 11697186.
DOI: 10.1038/s41598-024-83637-4.
Ijaz M, Zargar B, Nims R, McKinney J, Sattar S
Appl Environ Microbiol. 2024; 91(1):e0142624.
PMID: 39641606
PMC: 11784435.
DOI: 10.1128/aem.01426-24.
Peptide Aldehydes Incorporating Thiazol-4-yl Alanine Are Potent In Vitro Inhibitors of SARS-CoV-2 Main Protease.
Feys J, Edwards K, Joyce M, Saffran H, Shields J, Garcia K
ACS Med Chem Lett. 2024; 15(11):2046-2052.
PMID: 39563811
PMC: 11571010.
DOI: 10.1021/acsmedchemlett.4c00444.
Cholesterol and Cholesterol-Lowering Medications in COVID-19-An Unresolved Matter.
Grewal T, Nguyen M, Buechler C
Int J Mol Sci. 2024; 25(19).
PMID: 39408818
PMC: 11477656.
DOI: 10.3390/ijms251910489.
Salivary assessment of the immune/inflammatory responses and oxidative stress in older adults vaccinated with CoronaVac or ChadOx-1.
Vieira J, de Oliveira T, Queiroz L, Camargo C, Nardy A, Monteiro F
BMC Geriatr. 2024; 24(1):807.
PMID: 39363197
PMC: 11448442.
DOI: 10.1186/s12877-024-05357-8.
The Long-Term Cardiovascular Impact of COVID-19: Pathophysiology, Clinical Manifestations, and Management.
Mukkawar R, Reddy H, Rathod N, Kumar S, Acharya S
Cureus. 2024; 16(8):e66554.
PMID: 39258051
PMC: 11384648.
DOI: 10.7759/cureus.66554.
Intercellular Transport of Viral Proteins.
Simon F, Thoma-Kress A
Results Probl Cell Differ. 2024; 73:435-474.
PMID: 39242389
DOI: 10.1007/978-3-031-62036-2_18.
Bacterial Membrane Vesicles as a Novel Vaccine Platform against SARS-CoV-2.
Yilmaz Colak C
Curr Microbiol. 2024; 81(10):317.
PMID: 39164527
DOI: 10.1007/s00284-024-03846-y.
Research Progress on Spike-Dependent SARS-CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of Spike.
Freidel M, Armen R
Viruses. 2024; 16(5).
PMID: 38793593
PMC: 11125925.
DOI: 10.3390/v16050712.
Vascular dysfunction in hemorrhagic viral fevers: opportunities for organotypic modeling.
Zarate-Sanchez E, George S, L Moya M, Robertson C
Biofabrication. 2024; 16(3).
PMID: 38749416
PMC: 11151171.
DOI: 10.1088/1758-5090/ad4c0b.
Effect of polyphenols against complications of COVID-19: current evidence and potential efficacy.
Vajdi M, Karimi A, Hassanizadeh S, Farhangi M, Bagherniya M, Askari G
Pharmacol Rep. 2024; 76(2):307-327.
PMID: 38498260
DOI: 10.1007/s43440-024-00585-6.
Chemical and spectroscopic characterization of (Artemisinin/Querctin/ Zinc) novel mixed ligand complex with assessment of its potent high antiviral activity against SARS-CoV-2 and antioxidant capacity against toxicity induced by acrylamide in male....
El-Megharbel S, Qahl S, Albogami B, Hamza R
PeerJ. 2024; 12:e15638.
PMID: 38188145
PMC: 10768679.
DOI: 10.7717/peerj.15638.
The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity.
Escalera A, Laporte M, Turner S, Karakus U, Gonzalez-Reiche A, van de Guchte A
Emerg Microbes Infect. 2023; 13(1):2297553.
PMID: 38112266
PMC: 10866063.
DOI: 10.1080/22221751.2023.2297553.
Insights from the Construction of Adenovirus-Based Vaccine Candidates against SARS-CoV-2: Expecting the Unexpected.
Weklak D, Tisborn J, Mangold M, Scheu R, Wodrich H, Hagedorn C
Viruses. 2023; 15(11).
PMID: 38005833
PMC: 10675337.
DOI: 10.3390/v15112155.
Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors.
Mushebenge A, Ugbaja S, Mbatha N, Khan R, Kumalo H
Int J Mol Sci. 2023; 24(21).
PMID: 37958503
PMC: 10647470.
DOI: 10.3390/ijms242115518.
Viral Entry Inhibitors Protect against SARS-CoV-2-Induced Neurite Shortening in Differentiated SH-SY5Y Cells.
Mignolet M, Gilloteaux J, Halloin N, Gueibe M, Willemart K, De Swert K
Viruses. 2023; 15(10).
PMID: 37896797
PMC: 10611151.
DOI: 10.3390/v15102020.
SARS-CoV-2 spike S2-specific neutralizing antibodies.
Li C, Chang S
Emerg Microbes Infect. 2023; 12(2):2220582.
PMID: 37254830
PMC: 10274517.
DOI: 10.1080/22221751.2023.2220582.